Australia's Bioxyne jumps on entering German market with $3.7 mln deal
** Bioxyne BXN.AX jumps as much as 16.1% to A$0.036, highest since February 28 ** Pharmaceutical co enters German cannabis market with 3.2 mln-euro ($3.7 mln) manufacture and supply agreement ** Around 4.2 mln shares traded vs 30-day avg of 3.6 mln ** BXN last up 12.9%, takes YTD gains to 29.6% ($1 = 0.8703 euros) (Reporting by Shivangi Lahiri in Bengaluru) ((shivangi.lahiri@thomsonreuters.com))
Recent news on BLS Pharmaceuticals
See all newsBrief: Bioxyne Secures A$50M Exclusive German Supply Agreement With Adrex
Australia's Bioxyne rises to near 8-year high after company secures German supply deal
Australia's Bioxyne at two-week high on supply deal with Remidose LATAM
Brief: Bioxyne Expands LATAM Footprint First Supply Agreement Costa Rica
Australia's Bioxyne hits nearly 8-year high on cannabis firm deal